TSHA logo

Taysha Gene Therapies, Inc. (TSHA) Total Liabilities

Annual Total Liabilities:

$204.88M+$12.83M(+6.68%)
December 31, 2024

Summary

  • As of today, TSHA annual total liabilities is $204.88 million, with the most recent change of +$12.83 million (+6.68%) on December 31, 2024.
  • During the last 3 years, TSHA annual total liabilities has risen by +$86.31 million (+72.79%).
  • TSHA annual total liabilities is now at all-time high.

Performance

TSHA Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAbalance sheet metrics

Quarterly Total Liabilities:

$97.56M+$12.96M(+15.32%)
September 30, 2025

Summary

  • As of today, TSHA quarterly total liabilities is $97.56 million, with the most recent change of +$12.96 million (+15.32%) on September 30, 2025.
  • Over the past year, TSHA quarterly total liabilities has increased by +$6.14 million (+6.72%).
  • TSHA quarterly total liabilities is now -60.16% below its all-time high of $244.88 million, reached on September 30, 2023.

Performance

TSHA Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAbalance sheet metrics

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

TSHA Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+6.7%+6.7%
3Y3 Years+72.8%-2.8%
5Y5 Years+10000.0%+739.3%

TSHA Total Liabilities Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+72.8%-60.2%+17.1%
5Y5-Yearat high>+9999.0%-60.2%+1187.3%
All-TimeAll-Timeat high>+9999.0%-60.2%+1187.3%

TSHA Total Liabilities History

DateAnnualQuarterly
Sep 2025
-
$97.56M(+15.3%)
Jun 2025
-
$84.60M(+1.6%)
Mar 2025
-
$83.30M(-59.3%)
Dec 2024
$204.88M(+6.7%)
$204.88M(+124.1%)
Sep 2024
-
$91.42M(-0.1%)
Jun 2024
-
$91.53M(-7.7%)
Mar 2024
-
$99.15M(-48.4%)
Dec 2023
$192.06M(+50.4%)
$192.06M(-21.6%)
Sep 2023
-
$244.88M(+106.4%)
Jun 2023
-
$118.66M(+1.8%)
Mar 2023
-
$116.55M(-8.7%)
Dec 2022
$127.68M
$127.68M(+27.2%)
DateAnnualQuarterly
Sep 2022
-
$100.34M(-8.5%)
Jun 2022
-
$109.62M(-4.9%)
Mar 2022
-
$115.25M(-2.8%)
Dec 2021
$118.57M(+1464.5%)
$118.57M(+17.8%)
Sep 2021
-
$100.65M(+81.8%)
Jun 2021
-
$55.37M(+177.4%)
Mar 2021
-
$19.96M(+163.3%)
Dec 2020
$7.58M(+4952.7%)
-
Dec 2020
-
$7.58M(-34.8%)
Sep 2020
-
$11.62M(-42.1%)
Jun 2020
-
$20.09M
Dec 2019
$150.00K
-

FAQ

  • What is Taysha Gene Therapies, Inc. annual total liabilities?
  • What is the all-time high annual total liabilities for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. annual total liabilities year-on-year change?
  • What is Taysha Gene Therapies, Inc. quarterly total liabilities?
  • What is the all-time high quarterly total liabilities for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. quarterly total liabilities year-on-year change?

What is Taysha Gene Therapies, Inc. annual total liabilities?

The current annual total liabilities of TSHA is $204.88M

What is the all-time high annual total liabilities for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high annual total liabilities is $204.88M

What is Taysha Gene Therapies, Inc. annual total liabilities year-on-year change?

Over the past year, TSHA annual total liabilities has changed by +$12.83M (+6.68%)

What is Taysha Gene Therapies, Inc. quarterly total liabilities?

The current quarterly total liabilities of TSHA is $97.56M

What is the all-time high quarterly total liabilities for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high quarterly total liabilities is $244.88M

What is Taysha Gene Therapies, Inc. quarterly total liabilities year-on-year change?

Over the past year, TSHA quarterly total liabilities has changed by +$6.14M (+6.72%)
On this page